• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

延长的抑制性环境会导致脊髓性肌萎缩症中SMN2基因第7外显子跳跃。

An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy.

作者信息

Singh Natalia N, Androphy Elliot J, Singh Ravindra N

机构信息

Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605-2324, USA.

出版信息

Biochem Biophys Res Commun. 2004 Mar 5;315(2):381-8. doi: 10.1016/j.bbrc.2004.01.067.

DOI:10.1016/j.bbrc.2004.01.067
PMID:14766219
Abstract

SMN1 and SMN2 represent the two nearly identical copies of the survival of motor neuron gene in humans. The most frequent cause of spinal muscular atrophy (SMA) is loss of SMN1 accompanied by the inability of SMN2 to compensate due to an inhibitory mutation at position 6 in exon 7 (C6U) that causes exon 7 exclusion. How this single exonic nucleotide regulates exon 7 recognition has been of major interest. Based on score matrices and in vitro assays, abrogation of an exonic splicing enhancer (ESE) associated with SF2/ASF has been considered as the cause of exon 7 exclusion. However, a recent report supports the creation of an exonic splicing silencer (ESS) associated with hnRNP A1 as the determining factor for exon 7 exclusion. Here we show that C6U strengthens an inhibitory context that covers a larger sequence than the hnRNP A1 binding site. The inhibitory context can also be strengthened by the addition of a G residue at the first position of exon 7 in SMN1, promoting exon 7 skipping despite the presence of SF2/ASF binding site. Through in vivo selection and a series of mutations we demonstrate that the strengthening of the extended inhibitory context at the 5' end of exon 7 is exercised through overlapping sequence motifs that collaborate to regulate exon usage.

摘要

SMN1和SMN2代表人类运动神经元存活基因的两个几乎相同的拷贝。脊髓性肌萎缩症(SMA)最常见的病因是SMN1缺失,同时由于外显子7第6位(C6U)的抑制性突变导致外显子7被排除,使得SMN2无法发挥补偿作用。这一单外显子核苷酸如何调节外显子7的识别一直是人们主要关注的问题。基于评分矩阵和体外实验,与SF2/ASF相关的外显子剪接增强子(ESE)的缺失被认为是外显子7被排除的原因。然而,最近的一份报告支持与hnRNP A1相关的外显子剪接沉默子(ESS)的产生是外显子7被排除的决定性因素。在这里,我们表明C6U加强了一个抑制性环境,该环境覆盖的序列比hnRNP A1结合位点更大。在SMN1外显子7的第一位添加一个G残基也可以加强这种抑制性环境,尽管存在SF2/ASF结合位点,但仍会促进外显子7跳跃。通过体内筛选和一系列突变,我们证明外显子7 5'端延伸的抑制性环境的加强是通过重叠的序列基序实现的,这些基序共同协作调节外显子的使用。

相似文献

1
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy.延长的抑制性环境会导致脊髓性肌萎缩症中SMN2基因第7外显子跳跃。
Biochem Biophys Res Commun. 2004 Mar 5;315(2):381-8. doi: 10.1016/j.bbrc.2004.01.067.
2
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.脊髓性肌萎缩症基因SMN1和SMN2中第7外显子剪接的决定因素。
Am J Hum Genet. 2006 Jan;78(1):63-77. doi: 10.1086/498853. Epub 2005 Nov 16.
3
hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.异质性核糖核蛋白A1在抑制SMN2基因第7外显子剪接过程中具有特异性作用。
Hum Mol Genet. 2007 Dec 15;16(24):3149-59. doi: 10.1093/hmg/ddm276. Epub 2007 Sep 19.
4
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.SMN2中一个依赖于SF2/ASF的外显子剪接增强子的破坏在缺乏SMN1的情况下会导致脊髓性肌萎缩。
Nat Genet. 2002 Apr;30(4):377-84. doi: 10.1038/ng854. Epub 2002 Mar 4.
5
Evolving concepts on human SMN pre-mRNA splicing.关于人类生存运动神经元前体信使核糖核酸剪接的不断演变的概念。
RNA Biol. 2007 Jan-Mar;4(1):7-10. doi: 10.4161/rna.4.1.4535. Epub 2007 Jun 4.
6
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.SMN2基因第7外显子中的一个负性元件会抑制脊髓性肌萎缩症中的剪接过程。
Nat Genet. 2003 Aug;34(4):460-3. doi: 10.1038/ng1207.
7
An intronic element contributes to splicing repression in spinal muscular atrophy.一个内含子元件促成脊髓性肌萎缩症中的剪接抑制。
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3426-31. doi: 10.1073/pnas.0700343104. Epub 2007 Feb 16.
8
hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.异质性核糖核蛋白G(hnRNP-G)通过与丝氨酸蛋白酶Htra2-β1直接相互作用促进生存运动神经元(SMN)外显子7的包含。
Hum Mol Genet. 2002 Aug 15;11(17):2037-49. doi: 10.1093/hmg/11.17.2037.
9
In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes.体内筛选揭示了定义脊髓性肌萎缩症基因关键外显子的组合控制机制。
RNA. 2004 Aug;10(8):1291-305. doi: 10.1261/rna.7580704.
10
The regulation and regulatory activities of alternative splicing of the SMN gene.运动神经元存活基因(SMN)的可变剪接调控及其调控活动
Crit Rev Eukaryot Gene Expr. 2004;14(4):271-85. doi: 10.1615/critreveukaryotgeneexpr.v14.i4.30.

引用本文的文献

1
U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes.U1小核仁核糖核酸与内含子深处序列的相互作用调控脊髓性肌萎缩症基因多个外显子的剪接。
Front Neurosci. 2024 Jul 12;18:1412893. doi: 10.3389/fnins.2024.1412893. eCollection 2024.
2
Deciphering RNA splicing logic with interpretable machine learning.用可解释的机器学习破解 RNA 剪接逻辑。
Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2221165120. doi: 10.1073/pnas.2221165120. Epub 2023 Oct 5.
3
Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy.
针对脊髓性肌萎缩症的 SMN2 靶向剪接调节小分子治疗的多样化靶点。
Nucleic Acids Res. 2023 Jul 7;51(12):5948-5980. doi: 10.1093/nar/gkad259.
4
Base editing rescue of spinal muscular atrophy in cells and in mice.碱基编辑技术挽救细胞和小鼠中的脊髓性肌肉萎缩症。
Science. 2023 Apr 21;380(6642):eadg6518. doi: 10.1126/science.adg6518. Epub 2023 Apr 14.
5
Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts.Sam68 和 hnRNP A1 在外显子 7 从 SMN2 转录本中排除中的协同作用的结构与功能分析。
Protein Sci. 2023 Apr;32(4):e4553. doi: 10.1002/pro.4553.
6
When a Synonymous Variant Is Nonsynonymous.同义突变非同义。
Genes (Basel). 2022 Aug 19;13(8):1485. doi: 10.3390/genes13081485.
7
Structural Context of a Critical Exon of Spinal Muscular Atrophy Gene.脊髓性肌萎缩症基因关键外显子的结构背景
Front Mol Biosci. 2022 Jul 1;9:928581. doi: 10.3389/fmolb.2022.928581. eCollection 2022.
8
The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy.首款用于治疗脊髓性肌萎缩症的口服小分子药物。
Neurosci Insights. 2020 Nov 23;15:2633105520973985. doi: 10.1177/2633105520973985. eCollection 2020.
9
Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy.发现一种 CNS 穿透性小分子 SMN2 剪接调节剂,可改善脊髓性肌萎缩症的耐受性。
Sci Rep. 2020 Oct 15;10(1):17472. doi: 10.1038/s41598-020-74346-9.
10
Intrinsic Regulatory Role of RNA Structural Arrangement in Alternative Splicing Control.RNA 结构排列在可变剪接控制中的内在调节作用。
Int J Mol Sci. 2020 Jul 21;21(14):5161. doi: 10.3390/ijms21145161.